176 stories from 20 sources
The month in Mergers and Acquisitions
Longest running story: 27 days
Click on a headline to see stories that shaped it.
Threads
4 threads
GSK's $10.6 billion Nuvalent acquisition made targeted oncology a major portfolio priority. Later announcements from AbbVie and Merck connected that deal to a wider healthcare buying surge driven by pipeline replacement, laboratory tools, and patent-cliff pressure.
Paramount Skydance's proposed Warner Bros. Discovery acquisition moved from a UK competition probe to US Justice Department approval without divestitures, then encountered scrutiny over foreign investors. EU remedies later removed another major obstacle, bringing the transaction closer to completion while shifting attention to its closing conditions.
UniCredit moved toward a roughly 34% Commerzbank holding as its nearly two-year effort gained shareholder support. Germany's opposition at the close of the acceptance window transformed the campaign into a political and regulatory standoff.
Castlelake moved from weighing an EasyJet bid to pursuing shareholders after the airline rejected multiple proposals. The continued resistance and top holders' demand for a higher price left the airline's valuation unresolved by month's end.
Week’s Recap